Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Pseudoaldosteronism
ADR ID BADD_A10786
ADR Hierarchy
05      Endocrine disorders
05.01      Adrenal gland disorders
05.01.01      Adrenal cortical hyperfunctions
05.01.01.009      Pseudoaldosteronism
14      Metabolism and nutrition disorders
14.05      Electrolyte and fluid balance conditions
14.05.04      Sodium imbalance
14.05.04.013      Pseudoaldosteronism
24      Vascular disorders
24.08      Vascular hypertensive disorders
24.08.04      Endocrine and metabolic secondary hypertension
24.08.04.010      Pseudoaldosteronism
Description Familial pseudoaldosteronism characterized by autosomal dominant inheritance of hypertension with HYPOKALEMIA; ALKALOSIS; RENIN and ALDOSTERONE level decreases. It is caused by mutations in EPITHELIAL SODIUM CHANNELS beta and gamma subunits. Different mutations in the same EPITHELIAL SODIUM CHANNELS subunits can cause PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT. [MeSH]
MedDRA Code 10037113
MeSH ID D056929
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Pseudo aldosteronism | Pseudoaldosteronism | Pseudohyperaldosteronism | Liddle Syndrome | Syndrome, Liddle
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01217Itraconazole0.012025%
BADD_D01804Posaconazole0.234519%
BADD_D01971Rosuvastatin0.000017%
The 1th Page    1    Total 1 Pages